For Immediate Release

April 26, 2021

Sumitomo Chemical Announces Revisions to Its Financial Forecast andProjected Dividend for the Full Year Ended March 31, 2021
Based on recent performance trends, Sumitomo Chemical has made revisions to its consolidated
financial forecast for the full year ended March 31, 2021, previously announced on February 12,2021, and the projected dividend, previously announced on August 4, 2020, as detailed below.
1. Revisions to Consolidated Financial Forecast for the Full Year Ended March 31, 2021
(Millions of yen)
SalesrevenueCore
operatingincome *Operatingincome

Net income
attributable toowners of theparent

Earnings
per share(yen)Previous forecast (A)2,260,000

135,000

110,000

20,000

12.23

Revised forecast (B)2,285,000

147,000

137,000

46,00028.13

25,00012,00027,00026,000

1.1

8.9

24.5

130.0

2,225,804

132,652

137,51730,926

Variance in amount (B-A)
Variance in percentage (%)
Previous year results(Fiscal 2019)18.91* “Core Operating Income” excludes gains and losses from non-recurring factors from operating income.

(Reasons for the Revision)
Sales revenue and core operating income are expected to outperform the previously announced
forecast because better market conditions led to an improvement in the profit margin for thePetrochemicals & Plastics sector, and because of lower sales expenses, general andadministrative expense (SG&A) and research and development expense in the Health & Crop
Sciences and Pharmaceuticals sectors.
For non-recurring items which are not included in core operating income, in the Pharmaceuticals
sector, in which an impairment loss was included in the previous forecast, we no longer expect
an impairment loss on the in-progress research and development of TP-0903, an investigationalanti-cancer agent, following the revision of its development plan. In addition, for finance income
and finance expenses, because of the depreciation of the Japanese yen toward the end of thefiscal year, there is expected to be an improvement in the foreign currency translation
adjustment.
Therefore, operating income and net income attributable to owners of the parent are both
expected to be higher than the amounts in the previously announced forecast.

2. Revision to the Projected Dividend
Dividend per share
Second quarter-end

Fiscal year-end

Total

¥6.00

¥12.00¥9.00¥15.00¥6.00¥17.00Previous forecast(Announced on August 4, 2020)

Revised forecast
Actual¥6.00

Previous year results(Fiscal 2019)¥11.00(Reasons for the Revision)
The Company places a high priority on shareholder return and makes it a policy to maintain stabledividend payments, while giving due consideration to its business performance and a dividend
payout ratio for each fiscal year and the amount of retained earnings necessary for future growth.
As stated above, Sumitomo Chemical has made upward revisions to its full-year consolidated
finance forecast, and is therefore projecting a year-end dividend for fiscal 2020 of 9 yen per share.
This will result in a total annual dividend of 15 yen per share.

Cautionary Statement
Statements made in this document with respect to Sumitomo Chemical’s current plans, estimates,strategies and beliefs that are not historical facts are forward looking statements about the future
performance of Sumitomo Chemical. These statements are based on management’s assumptions
and beliefs in light of the information currently available to it, and involve risks and uncertainties.
The important factors that could cause actual results to differ materially from those discussed in
the forward looking statements include, but are not limited to, general economic conditions in
Sumitomo Chemical’s markets; demand for, and competitive pricing pressure on, Sumitomo
Chemical’s products in the marketplace; Sumitomo Chemical’s ability to continue to win
acceptance for its products in these highly competitive markets; and movements of currency
exchange rates.

Information:
Financial Forecast by Segment for the Full Year Ended March 31, 2021
(Millions of yen)
Fiscal 2020
Previous
Forecast (A)Fiscal 2020
Revised
Forecast (B)Variance inAmount (B-A)

Petrochemicals &Plastics

Sales revenue

570,000

590,000

20,000Core operating income-18,000-12,000

6,000

Energy & Functional
Materials

Sales revenue

240,000

245,000

5,000Core operating income

18,00020,0002,000

Sales revenue

425,000

430,000

5,000Core operating income

40,00040,000－

Sales revenue

425,000

425,000－

Core operating income

27,00031,5004,500

Sales revenue

545,000

545,000－

Core operating income

65,00071,5006,500

Sales revenue

55,00050,000-5,000Core operating income

3,000-4,000-7,0002,260,000

2,285,000

25,000135,000

147,000

12,000IT-related Chemicals
Health & Crop
Sciences
Pharmaceuticals
OthersAdjustments
Total

Sales revenue
Core operating income